Description Features Reviews
Immunogenicity / peptide safety Verify peptide purity, endotoxin levels, proper storage and handling
Indications and Usage for Imcivree IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged [ see Dosage and Administration (2.1)]: 4 years and older with acquired hypothalamic obesity (HO) 2 years and older with syndromic or monogenic obesity due to: o Bardet-Biedl syndrome (BBS) o Pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS)
The administration is getting way out ahead of its own safety agency. An oral version of Wegovy, from Novo Nordisk, is being reviewed by the FDA
Because methylcobalamin is classed as a nutritional supplement and is not a licensed prescription only medicine in the UK, it is not available via the NHS and is being offered more and more by non-healthcare and non-prescribing practitioners as a treatment for wellness, fatigue, and to boost energy, without making any medical claims around deficiency, and is rarely combined with a supplement of adenosylcobalamin
[11] Other chelating agents, such as 2,3-dimercaptopropanesulfonic acid (DMPS) and alpha lipoic acid (ALA), are used in conventional and alternative medicine